Results 181 to 190 of about 59,241 (243)

Use of Naltrexone for Patients With Stimulant Use Disorder in Malaysia: Protocol for a Retrospective Cohort Study.

JMIR Res Protoc
Muhamad NA, Ma'amor NH, Muhamad Rasat MA, Tengku Baharudin Shah TPN, Rosli '', Leman FN, Jamalluddin NH, Misnan NS, Chemi N, Abdullah N, Ibrahim N, My Addiction Study group.   +11 more
europepmc   +1 more source

Behavioral Therapy as an Adjunct to Buprenorphine Treatment for Opioid Use Disorder: A Secondary Analysis of 4 Randomized Clinical Trials.

JAMA Netw Open
McHugh RK, Bailey AJ, McConaghy BA, Weiss RD, Fiellin DA, Hillhouse M, Moore BA, Fitzmaurice GM.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Naloxone in heroin dependence

Clinical Pharmacology & Therapeutics, 1968
Naloxone is a potent and rapidly acting narcotic antagonist, with a duration of action which is shorter (3 to 4 hours) than that of heroin. In a clinical trial of naloxone in the treatment of heroin dependence, a daily oral dose of 100 mg. at 8 A.M. and 7 P.M. effectively blockaded 20 mg.
Arnoldo Mora, Stephen Levit, Arthur Zaks, Alfred Bruner, Robert L. Sharoff, Max Fink, Alfred M. Freedman   +6 more
openaire   +3 more sources

Acute effects of heroin on emotions in heroin‐dependent patients

The American Journal on Addictions, 2013
BackgroundEuphoria has been described in heroin‐dependent individuals after heroin administration. However, affective disturbances and disorders are common in heroin dependence. The present study examined the acute effects of heroin on emotions in heroin‐dependent patients.MethodsThis randomized controlled crossover trial included 28 heroin‐dependent ...
Blum, J., Gerber, H., Gerhard, U., Schmid, O., Petitjean, S., Riecher-Rössler, A., Wiesbeck, G. A., Borgwardt, S. J., Walter, M.   +8 more
openaire   +4 more sources